- Home
- ACAD vs ICFI Comparison
ACAD vs ICFI Comparison
Compare ACAD & ICFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACAD
- ICFI
- Stock Information
- Founded
- ACAD 1993
- ICFI 1969
- Country
- ACAD United States
- ICFI United States
- Employees
- ACAD N/A
- ICFI N/A
- Industry
- ACAD Biotechnology: Pharmaceutical Preparations
- ICFI Professional Services
- Sector
- ACAD Health Care
- ICFI Consumer Discretionary
- Exchange
- ACAD Nasdaq
- ICFI Nasdaq
- Market Cap
- ACAD 2.6B
- ICFI 2.9B
- IPO Year
- ACAD 2004
- ICFI 2006
- Fundamental
- Price
- ACAD $16.07
- ICFI $159.26
- Analyst Decision
- ACAD Buy
- ICFI Buy
- Analyst Count
- ACAD 18
- ICFI 4
- Target Price
- ACAD $26.44
- ICFI $159.75
- AVG Volume (30 Days)
- ACAD 1.5M
- ICFI 71.7K
- Earning Date
- ACAD 10-31-2024
- ICFI 10-31-2024
- Dividend Yield
- ACAD N/A
- ICFI 0.35%
- EPS Growth
- ACAD N/A
- ICFI 52.74
- EPS
- ACAD 0.19
- ICFI 5.21
- Revenue
- ACAD $890,534,000.00
- ICFI $1,986,336,000.00
- Revenue This Year
- ACAD $33.69
- ICFI $7.17
- Revenue Next Year
- ACAD $11.41
- ICFI $6.99
- P/E Ratio
- ACAD $86.67
- ICFI $30.58
- Revenue Growth
- ACAD 61.65
- ICFI 3.09
- 52 Week Low
- ACAD $14.55
- ICFI $115.67
- 52 Week High
- ACAD $32.59
- ICFI $167.91
- Technical
- Relative Strength Index (RSI)
- ACAD 52.87
- ICFI 53.03
- Support Level
- ACAD $15.49
- ICFI $163.19
- Resistance Level
- ACAD $17.03
- ICFI $167.91
- Average True Range (ATR)
- ACAD 0.42
- ICFI 3.07
- MACD
- ACAD -0.78
- ICFI -0.74
- Stochastic Oscillator
- ACAD 94.36
- ICFI 17.38
About ACAD ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecules drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
About ICFI ICF International Inc.
ICF International Inc provides professional services and technology-based solutions to government and commercial clients, including management, marketing, technology, and policy consulting and implementation services. Its services support clients that operate in four key markets that include Energy, Environment, Infrastructure and Disaster Recovery; Health and Social Programs and Security and Other Civilian & Commercial. The Company's majority clients are United States federal government departments and agencies. It operates in single segment, which is providing professional services.